Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04321811Completed

Behavior, Environment And Treatments for Covid-19

Role: collaborator

NCT03749629Not ApplicableCompleted

Comparative Effectiveness of Pharmacogenomics for Treatment of Depression

Role: collaborator

NCT03844321Not ApplicableCompleted

Healthy Mind Healthy You: A Study of Mindfulness

Role: collaborator

NCT02744846Completed

Short- and Long-Term Effects of Antibiotics on Childhood Growth

Role: collaborator

All 4 trials loaded